FDA approves Eli Lilly’s once-weekly insulin injection for type 2 diabetes

The US Food and Drug Administration has approved Eli Lilly’s once-weekly basal insulin, Onswik, for adults with type ​2 diabetes, the drugmaker said on Thursday, offering patients ‌an alternative to ...
MedPage Today on MSN

FDA approves Efsitora weekly insulin for type 2 diabetes

Approval marks the second once-weekly basal insulin for this population ...
PR Newswire

U.S. Food and Drug Administration (FDA) approves Lilly's Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin injection treatment for adults living with type 2 ...

Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin efsitora alfa-gobe), ...
Today

How to use basal insulin to help manage your diabetes

Dr. Marie McDonnell, the director of the Brigham Diabetes Program at Brigham and Women’s Hospital in Boston, told TODAY that basal insulin is a long-acting insulin therapy that helps the body process ...
Healio

Once-weekly basal insulin noninferior to once-daily insulin for type 1, type 2 diabetes

Please provide your email address to receive an email when new articles are posted on . Change in HbA1c and hypoglycemia rates were similar between once-weekly basal insulin and once-daily insulin ...
Yahoo Finance

LLY's Onswik Wins FDA Nod as a Once-Weekly Basal Insulin for T2D

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Healio

Automated insulin delivery may expedite basal insulin dose titration in type 2 diabetes

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
FierceBiotech

FDA clears Dexcom's Type 2 diabetes software for optimizing basal insulin doses

Dexcom said Smart Basal works to dial in a personalized background insulin dose by checking all of a user's CGM readings, not a fasting blood sugar check. (Dexcom) Dexcom has obtained an FDA clearance ...

Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200

The FDA just handed Eli Lilly a new diabetes approval, but the real debate is whether a once-weekly insulin needle moves the ...

Continuous glucose monitoring may lower mortality risk in diabetic patients on insulin

People with type 2 diabetes (T2D) who began using continuous glucose monitoring (CGM) while receiving basal insulin had a 44% ...
The American Journal of Managed Care

Economic Burden of Hypoglycemia With Basal Insulin in Type 2 Diabetes

Hypoglycemia after basal insulin initiation is associated with high clinical and economic burden that precedes insulin initiation and persists during 1 to 2 years of follow-up. Objectives: To assess ...
Medscape

Once-Weekly Basal Insulin Nears Market for Type 2 Diabetes

SAN DIEGO – The investigational once-weekly insulin icodec provided superior glucose control compared with the once-daily basal insulins degludec and glargine in type 2 diabetes, results from two new ...